P-48 The potential role and scope of integrative oncology on the quality of life of patients diagnosed with breast cancer, colon and metastatic prostate cancer who are on active treatment in the Haema
Author(s):
L Reid, D Brady-West
Year of Presentation:
2023
Objective: To assess the quality of life of patients diagnosed with breast, colon and metastatic prostate cancer who are on active treatment and the potential role of Integrative Oncology in impacting quality of life.
Methods: A sample of 52 patients diagnosed with breast cancer, colon cancer and metastatic prostate cancer on chemotherapy at the UHWI were enrolled in this cross sectional study. Quality of life was assessed using the abridged version of The WHO quality of life scale questionnaire. The Pearson Chi-squared test was used to determine the association between different variables and the quality of life.
Results: Quality of life was rated as good (55.8%) and very good (28.8%) for most participants. Only one participant (1.9%) rated the quality of life as poor, and no respondent indicated a very poor quality of life.
Conclusion: Quality of life scores were noted to be good and very good in the majority of participants diagnosed with breast cancer, colon cancer or metastatic prostate cancer at the UHWI.There however were lower scores in the psychological domain for patients with colon cancer. There are also also limited dietary and psychology referrals noted in this study. Despite the high quality of life scores noted here, the literature has highlighted the significant impact of integrative oncology.